Newron Pharmaceuticals to Request Type A FDA Meeting Prior to Unblinding of STARS Clinical Trial Data

Bencard Allergie GmbH: Allergy Therapeutics announces update to Grass MATA MPL phase III clinical programme

MagForce AG:New hope for brain tumor patients in Saxony: Paracelsus Clinic Zwickau and MagForce AG open new NanoTherm therapy center for the East German region

Apogenix to Present New Data on Asunercept at ESMO Immuno-Oncology Congress

InfanDx completes enrollment for BANON study evaluating its diagnostic HypoxE-test® for newborn asphyxia

ADL Bionatur Solutions Wins New Fermentation Client With Contract Revenues of EUR 20 Million

Ergomed plc: Lewis Cameron, Former Head of Global Clinical Development at Covance, Appointed as Chief Operating Officer

ViGeneron announces closing of series A financing to drive development of next generation gene

Proteros, co-founder of Rodin Therapeutics, announces Rodin’s acquisition by Alkermes

Vivoryon Therapeutics Reports Third Quarter 2019